Similar patterns of loss of heterozygosity in serum of adenocarcinoma of the distal oesophagus and the cardia in early diagnosis

Anticancer Research

Volumn 27, Issue 1 A, 2007, Pages 477-482

  Wachowiak, Robin ^a   Kaifi, Jussuf T ^a   Schurr, Paulus G ^a   Merkert, Petra ^a   Yekebas, Emre ^a   Schwarzenbach, Heidi ^a   Strate, Tim ^a   Sauter, Guido ^a   Izbicki, Jakob R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Gastric adenocarcinoma; Loss of heterozygosity; Microsatellite analysis; Oesophageal adenocarcinoma; Serum

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CARDIA CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; HETEROZYGOSITY; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARDIA; ESOPHAGEAL NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 33847661230     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Botterweck AAM, Schouten LJ, Volovics A, Dorant E and van den Brandt PA: Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 29: 645-654, 2000.
2. Ionov Y, Peinado MA, Malkhosyan S, Shibata D and Perucho M: Ubiquitous somatic mutations in simple repeat sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558-561, 1993.
3. Thibodeau SN, Bren G and Schaid D: Microsatellite instability in cancer of the proximal colon. Science 260: 816-819, 1993.
4. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J and Sidransky D: Molecular detection of tumour cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 91: 332-339, 1999.
5. Arvanitis DA, Papadakis E, Zafiropoulos A and Spandidos DA: Fractional allele loss is a valuable marker for human lung cancer detection in sputum. Lung Cancer 40: 55-66, 2003.
6. Grady WM, Rajput A, Lutterbaugh JD and Markowitz SD: Detection of aberrantly methylated hMLH1 promoter DNA in serum of patients with microsatellite unstable colon cancer. Cancer Res 61: 900-902, 2001.
7. Jen J, Wu L and Sidransky D: an overview on the isolation and analysis of circulation tumour DNA in plasma and serum. Ann NY Acad Sci 906: 8-12, 2000.
8. Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, De Meester TR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV and Meltzer SJ: Hypermethylated APC DNA in plasma and prognosis of patients with oesophageal adenocarcinoma. J Nat Cancer Inst 92: 1805-1811, 2000.
9. Schwarzenbach H, Muller V, Stahmann N and Pantel K: Detection and characterization of circulating microsatellite- DNA in blood of patients with breast cancer. Ann NY Acad Sci 1022: 25-32, 2004.
10. Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Engles J, Danenberg PV, Yang S and Sidransky D: Quantitative adenomatous polyposis coli promoter methylation analysis in tumour tissue, serum and plasma DNA of patients with lung cancer. Cancer Res 62: 371-375, 2002.
11. Gonzalgo ML, Eisenberger CF, Lee SM, Trock BJ, Marshall FF, Hortopan S, Sidransky D and Schoenberg MP: Prognostic significance of preoperative molecular serum analysis in renal cancer. Clin Cancer Res 8: 1878-1881, 2002.
12. Nakayama T, Taback B, Nguyen DH, Chi DD, Morton DL, Fujiwara Y and Hoon DSB: Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients. Circulating Nucleic Acids in Plasma or Serum 906: 87-98, 2000.
13. Nawroz-Danish H, Eisenberger CF, Yoo GH, Wu L, Koch W, Black C, Ensley JF, Wei WZ and Sidransky D: Microsatellite analysis in patients with head and neck cancer. Int J Cancer 111: 96-100, 2004.
14. Taback B, Fujiwara Y, Wang HJ, Foshag LJ, Morton DL and Hoon DSB: Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients. Cancer Res 61: 5723-5726, 2001.
15. Zhou X, Kemp BL, Khuri FR, Liu D, Lee JJ, Wu W, Hong WK and Mao L: Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Clin Cancer Res 6: 559-565, 2000.
16. Casson AG and Van Lanschot JJB: Improving outcomes after esophagectomy: The impact of operative volume. J Surg Oncol 92: 262-266, 2005.
17. Wu TT, Watannabe T, Heitmiller R, Zahurak M, Forastiere AA and Hamilton SR: Genetic alterations in Barrett esophagus and adenocarcinoma of the esophagus and esophagogastric junction region. Am J Pathol 153: 287-294, 1998.
18. Gleeson CM, Sloan JM, McGuigan JA, Ritchie AJ, Weber JL and Rusell SEH: Widespread microsatellite instabilty occours infrequently in adenocarcinoma of the gastric cardia. Oncogene 12: 1653-1662, 1996.
19. Moskaluk CA, Hu J and Perlman EJ: Comparative genomic hybridization of esophageal and gastroesophageal adenocarcinomas shows consensus areas of DNA gain and loss. Genes Chromosomes & Cancer 22: 305-311, 1998.
20. Koppert LB, Wijnhoven BP, Van Dekken H, Tilanus HW and Dinjens WN: The molecular biology of esophageal adenocarcinoma. J Surg Oncol 92: 169-190, 2005.
21. Keller G, Rotter M, Vogelsang H, Bischoff P, Becker KF, Mueller J, Brauch H, Siewert JR and Hofler H: Microsatellite instability in adenocarcinoma of the upper gastrointestinal-tract-relation to clinicopathological data and family history. Am J Pathol 147: 593-600, 1995.
22. Yanagi M, Keller G, Mueller J, Walch A, Werner M, Stein HJ, Siewert JR and Hofler H: Comparison of loss of heterozygosity and microsatellite instability in adenocarcinoma of the distal esophagus and proximal stomach. Virchows Archiv 437: 605-610, 2000.
23. von Knobloch R, Brandt H, Schrader AJ, Heidenreich A and Hofmann R: Molecular serological detection of DNA alterations in transitional cell carcinoma is highly sensitive and stage independent. Clin Cancer Res 10: 988-993, 2004.
24. Owonikoko T, Rees M, Gabbert HE and Sarbia M: Intratumoural genetic heterogeneity in Barrett adenocarcinoma. Am J Clin Pathol 177: 558-566, 2002.